Status:
ACTIVE_NOT_RECRUITING
Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
Cancer Prevention Research Institute of Texas
Conditions:
Liver and Intrahepatic Bile Duct Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial studies the use of surveys, blood testing, and fibroscan in screening for liver fibrosis and liver cirrhosis in new or existing patients of the HOPE clinic seeking usual clinical c...
Detailed Description
PRIMARY OBJECTIVE: I. To estimate the sensitivity of the modified Center for Disease Control (CDC) hepatitis survey in diagnosing chronic hepatitis B virus (HBV) among HOPE clinic patient. SECONDARY...
Eligibility Criteria
Inclusion
- Must be at least 18 years old
- Must be a new or existing patient of the HOPE clinic seeking usual clinical care
- Must be able to speak and read English or a language other than English for which there is a translator available on site at the HOPE clinic
Exclusion
- Known pregnancy at time of recruitment. The HOPE clinic will ask the female patients if they are pregnant, will ask the participants for their last menstrual period (LMP), and/or they will use the urine pregnancy test (UPT) results in their electronic medical records
Key Trial Info
Start Date :
December 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04785534
Start Date
December 22 2020
End Date
August 31 2026
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030